Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity
- PMID: 27443386
- DOI: 10.1039/c6ob01160h
Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity
Abstract
Natural products with anti-cancer activity play a vital role in lead and target discovery. We report here the synthesis and biological evaluation of the plant-derived alkaloid, piperlongumine and analogues. Using a Horner-Wadsworth-Emmons coupling approach, a selection of piperlongumine-like compounds were prepared in good overall yield from a novel phosphonoacetamide reagent. A number of the compounds displayed potent anti-cancer activity against colorectal (HCT 116) and ovarian (IGROV-1) carcinoma cell lines, via a mechanism of action which may involve ROS generation. Contrary to previous reports, no selective action in cancer cell (MRC-5) was observed for piperlongumine analogues.
Similar articles
-
Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.Eur J Med Chem. 2014 Jul 23;82:545-51. doi: 10.1016/j.ejmech.2014.05.070. Epub 2014 Jun 2. Eur J Med Chem. 2014. PMID: 24937186
-
Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol.Bioorg Med Chem Lett. 2017 Mar 1;27(5):1325-1328. doi: 10.1016/j.bmcl.2016.08.016. Epub 2016 Aug 6. Bioorg Med Chem Lett. 2017. PMID: 28159415
-
Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.Bioorg Med Chem Lett. 2018 Aug 1;28(14):2566-2572. doi: 10.1016/j.bmcl.2018.05.025. Epub 2018 May 14. Bioorg Med Chem Lett. 2018. PMID: 29807795
-
Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.Eur J Med Chem. 2018 Aug 5;156:13-20. doi: 10.1016/j.ejmech.2018.06.057. Epub 2018 Jun 25. Eur J Med Chem. 2018. PMID: 30006159 Review.
-
Overview of piperlongumine analogues and their therapeutic potential.Eur J Med Chem. 2021 Aug 5;220:113471. doi: 10.1016/j.ejmech.2021.113471. Epub 2021 Apr 21. Eur J Med Chem. 2021. PMID: 33930801 Review.
Cited by
-
The promising potential of piperlongumine as an emerging therapeutics for cancer.Explor Target Antitumor Ther. 2021;2(4):323-354. doi: 10.37349/etat.2021.00049. Epub 2021 Aug 30. Explor Target Antitumor Ther. 2021. PMID: 36046754 Free PMC article. Review.
-
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation.Front Oncol. 2021 Oct 21;11:745590. doi: 10.3389/fonc.2021.745590. eCollection 2021. Front Oncol. 2021. PMID: 34745968 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources